PTPRC and neoplasm: The digital spatial profiling (DSP) technology 9 was used to measure immune cell fractions, immune checkpoints, immune function, activities of HLA genes, immune cell functions impacting survival, and prognostic biomarkers in tumor cells (PanCK-expressing) and in immune cells areas (CD45-expressing).